224 related articles for article (PubMed ID: 31366623)
1. Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.
de Maat S; Sanrattana W; Mailer RK; Parr NMJ; Hessing M; Koetsier RM; Meijers JCM; Pasterkamp G; Renné T; Maas C
Blood; 2019 Nov; 134(19):1658-1669. PubMed ID: 31366623
[TBL] [Abstract][Full Text] [Related]
2. C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis.
Grover SP; Kawano T; Wan J; Tanratana P; Polai Z; Shim YJ; Snir O; Brækkan S; Dhrolia S; Kasthuri RR; Bendapudi PK; McCrae KR; Wolberg AS; Hansen JB; Farkas H; Mackman N
Blood; 2023 May; 141(19):2390-2401. PubMed ID: 36701760
[TBL] [Abstract][Full Text] [Related]
3. The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of alpha1-proteinase inhibitor M358R for thrombin.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Haemost; 2007 Nov; 98(5):1014-23. PubMed ID: 18000606
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
[TBL] [Abstract][Full Text] [Related]
5. An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema.
Liu J; Qin J; Borodovsky A; Racie T; Castoreno A; Schlegel M; Maier MA; Zimmerman T; Fitzgerald K; Butler J; Akinc A
RNA; 2019 Feb; 25(2):255-263. PubMed ID: 30463937
[TBL] [Abstract][Full Text] [Related]
6. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations.
de Maat S; Björkqvist J; Suffritti C; Wiesenekker CP; Nagtegaal W; Koekman A; van Dooremalen S; Pasterkamp G; de Groot PG; Cicardi M; Renné T; Maas C
J Allergy Clin Immunol; 2016 Nov; 138(5):1414-1423.e9. PubMed ID: 27130860
[TBL] [Abstract][Full Text] [Related]
7. Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.
de Maat S; Joseph K; Maas C; Kaplan AP
Clin Rev Allergy Immunol; 2021 Jun; 60(3):348-356. PubMed ID: 33956309
[TBL] [Abstract][Full Text] [Related]
8. Activation of the contact system in patients with a first acute myocardial infarction.
Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H
Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628
[TBL] [Abstract][Full Text] [Related]
9. Ongoing contact activation in patients with hereditary angioedema.
Konings J; Cugno M; Suffritti C; Ten Cate H; Cicardi M; Govers-Riemslag JW
PLoS One; 2013; 8(8):e74043. PubMed ID: 24013493
[TBL] [Abstract][Full Text] [Related]
10. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.
Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
Mol Immunol; 2020 Mar; 119():27-34. PubMed ID: 31955064
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of hereditary angioedema.
Zuraw BL; Christiansen SC
Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
Finotti P; de Laureto PP
Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium.
Dhami R; Zay K; Gilks B; Porter S; Wright JL; Churg A
J Mol Med (Berl); 1999 Apr; 77(4):377-85. PubMed ID: 10353442
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
Scott CF; Carrell RW; Glaser CB; Kueppers F; Lewis JH; Colman RW
J Clin Invest; 1986 Feb; 77(2):631-4. PubMed ID: 3484755
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
[TBL] [Abstract][Full Text] [Related]
16. Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization.
Berthelier V; Harris JB; Estenson KN; Baudry J
PLoS One; 2015; 10(5):e0126256. PubMed ID: 25961288
[TBL] [Abstract][Full Text] [Related]
17. Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.
Björkqvist J; de Maat S; Lewandrowski U; Di Gennaro A; Oschatz C; Schönig K; Nöthen MM; Drouet C; Braley H; Nolte MW; Sickmann A; Panousis C; Maas C; Renné T
J Clin Invest; 2015 Aug; 125(8):3132-46. PubMed ID: 26193639
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
[TBL] [Abstract][Full Text] [Related]
19. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
20. Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
Sheffield WP; Eltringham-Smith LJ; Bhakta V; Gataiance S
Thromb Haemost; 2012 May; 107(5):972-84. PubMed ID: 22370677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
